Bello · Current medical research and opinion 2006 · narrative review · n=7 studies

Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature.

Cited 199 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative literature review synthesizing preclinical mechanisms and clinical studies without systematic review methodology

PubMed 17076983 · doi:10.1185/030079906X148373 · record verified 2026-08-29

What was done

The authors reviewed preclinical and clinical literature on orally administered collagen hydrolysate for osteoarthritis and other joint disorders. Literature was retrieved via PubMed searches through May 2006 alongside scientific congress abstracts and German-language medical publications selected based on the authors' judgment. Preclinical mechanism studies and seven clinical trials (four open-label and three double-blind) were evaluated.

What was found

Preclinical research showed that orally administered collagen hydrolysate is absorbed intestinally, accumulates in cartilage, and significantly increases extracellular matrix macromolecule synthesis by chondrocytes (p < 0.05 compared with untreated controls). The seven identified clinical studies reported collagen hydrolysate was safe and provided improvements in select measures of pain and physical function in patients with osteoarthritis or other arthritic conditions; however, many studies omitted key statistical data, and no numerical clinical effect sizes are reported in the abstract.

Why it matters

This review outlines the early biological rationale and preliminary clinical evidence supporting collagen hydrolysate supplementation for joint disorders, while highlighting substantial gaps in clinical reporting standards.

Limits

This is a narrative review using subjective inclusion criteria rather than a rigorous systematic review. The clinical evidence base was small (seven trials) and characterized by incomplete reporting, such as omitted statistical significance tests, with no participant counts or effect sizes provided in the abstract.

Cited by